Background: Acute syphilis-infection was associated with blips, i.e. a timely limited HIV-1 virus load (VL)-increase, during otherwise suppressive antiretroviral therapy (ART), and the central nervous system (CNS) inflammation could be a virus reservoir. Purpose of this study was to explore if syphilisco-infection leads to increased CNS-replication of HIV-1. Methodology: Retrospective case-control study from a large German HIV-treatment unit, data were collected from 2005-2013; cerebrospinal fluid (CSF) was collected for various reasons in patients with or without neurological symptoms. Patients were eligible, if paired VL-results from simultaneous HIV-1 assessments in CSF and blood plasma were available, in addition to syphilis serology details, ART and clinical/demographic data; VL-ratio for CSF/blood was built for each patient. If TPPA-screening result was positive, further tests (VDRL, IgM, CSF/blood-antibody ratio) allowed patient grouping into latent, acute, or confirmed neuro-syphilis, enabling statistical evaluation of HIV-1 CNS-replication. Results: 179 HIV-1 infected patients were evaluable: 123 control-patients with negative screening result, and 56 patients with positive TPPA; out of these, 18 had confirmed acute syphilis infection; among these, 10 had neuro-syphilis, as of CSF-evaluation result. In comparisons between syphilis seropositivessubgroups, each versus controls, no significant difference for HIV-1 VL was found in CSF, blood and CSF/blood-ratio. Positive syphilis serology affected predominantly males (91.1%, vs. controls: 70.7%; p=0.005). Patients were older at first positive HIV-test (p<0.001) and still at time of CSF-collection (p=0.003). Comparing all syphilis seropositives with controls for antiretroviral therapy, the rate receiving it was similar (61.0% vs. 59.3%), but lower for those with acute syphilis infection (35.3%, p<0.05 vs. controls; see Table). Conclusions: HIV-1 replication in CSF, blood, and CSF/blood VL-ratio was not higher and not significantly different between patient groups with syphilis seropositive status, confirmed acute, or neuro-infection, respectively, and syphilis seronegative controls. This unselected cross-section study from a large treatment cohort could not support the hypothesis of a CNS reservoir for HIV-1 throughout different stages of syphilis infection. Patient characteristics are reflecting a high proportion of HIV-late presenters among those with acute syphilis disease.